Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9093312 | 0.81 | — | — | |
| SCHEMBL15520340 | 0.78 | TSHR (0.40) | MAPK1 | |
| SCHEMBL10625732 | 0.78 | MAPK1 (0.40) | MAPK1 | |
| SCHEMBL8071629 | 0.73 | MAPK1 (0.36) | MAPK1 | |
| SCHEMBL10755263 | 0.73 | MAPK1 (0.36) | MAPK1 | |
| SCHEMBL996605 | 0.69 | ALDH1A1 (0.30) | — | |
| SCHEMBL10408510 | 0.67 | — | — | |
| SCHEMBL3801738 | 0.67 | — | — | |
| SCHEMBL11796391 | 0.67 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL467778 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536568-B | Method for continuously synthesizing chlorfenapyr | 湖南化工研究院有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-115536568-A | Method for continuously synthesizing chlorine chlorfenapyr | 湖南化工研究院有限公司 | 2022-12-30 | — | — | CN | claimed |
| EP-0287007-B1 | PROCESS FOR CLEAVING ALIPHATIC ETHER COMPOUNDS | THE DOW CHEMICAL COMPANY (US) | 1992-01-22 | — | — | EP | claimed |
| CN-115536568-B | Method for continuously synthesizing chlorfenapyr | 湖南化工研究院有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-115536568-B | Method for continuously synthesizing chlorfenapyr | 湖南化工研究院有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-115536568-A | Method for continuously synthesizing chlorine chlorfenapyr | 湖南化工研究院有限公司 | 2022-12-30 | — | — | CN | disclosed |
| CN-115536568-A | Method for continuously synthesizing chlorine chlorfenapyr | 湖南化工研究院有限公司 | 2022-12-30 | — | — | CN | disclosed |
| EP-3004282-B1 | ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-21 | — | — | EP | disclosed |
| EP-3004282-A1 | ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION | Dow Global Technologies LLC (US) | 2016-04-13 | — | — | EP | disclosed |
| US-20160083643-A1 | ENHANCED OIL RECOVERY METHOD EMPLOYING A BIODEGRADABLE BRINE TOLERANT FOAM-FORMING COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-03-24 | — | — | US | disclosed |
| US-9187507-B2 | Acyclic nucleoside phosphonate derivatives and medical uses thereof | INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA (CN) | 2015-11-17 | — | — | US | disclosed |
| CN-1670016-A | Arylpyrrole compound with insecticidal, acaricidal and fungicidal biological activity and preparation method thereof | HUNAN RES INST OF CHEMICAL IND (CN) | 2005-09-21 | — | — | CN | disclosed |
| EP-1549644-A1 | AZOLIDINONE-VINYL FUSED-BENZENE DERIVATIVES | Applied Research Systems ARS Holding N.V. (AN) | 2005-07-06 | — | — | EP | disclosed |
| EP-1531813-A1 | USE OF COMPOUNDS FOR INCREASING SPERMATOZOA MOTILITY | Applied Research Systems ARS Holding N.V. (AN) | 2005-05-25 | — | — | EP | disclosed |
| US-20040092561-A1 | Azolidinone-vinyl fused -benzene derivatives | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2004-05-13 | — | — | US | disclosed |
| WO-2004007491-A1 | AZOLIDINONE-VINYL FUSED-BENZENE DERIVATIVES | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2004-01-22 | — | — | WO | disclosed |
| WO-2004006916-A1 | USE OF COMPOUNDS FOR INCREASING SPERMATOZOA MOTILITY | APPLIED RESEARCH SYSTEMS ARS HOLDING NV (AN) | 2004-01-22 | — | — | WO | disclosed |
| US-5256783-A | Method for producing 2-isoquinoline compounds | HOFFMANN-LA ROCHE INC. (US) | 1993-10-26 | — | — | US | disclosed |
| EP-0287007-B1 | PROCESS FOR CLEAVING ALIPHATIC ETHER COMPOUNDS | THE DOW CHEMICAL COMPANY (US) | 1992-01-22 | — | — | EP | disclosed |
| US-4568700-A | NONCARCINOGEN | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1986-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092561-A1 | Azolidinone-vinyl fused -benzene derivatives | BRCA1, ZAP70, ZYX | MAPK1 3500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.